抑郁症第1部分:评估
1Departments of Psychiatry and Behavioral Sciences and Pediatrics, Montefiore Health Systems/Albert Einstein College of Medicine, Bronx, NY.
Pediatrics in review
|August 31, 2024
概括
大型抑郁症影响五分之一的青少年,增加了自杀风险. 儿科医生可以通过在初级保健机构内查易受伤害的青少年的抑郁和自杀来改善心理健康平等.
科学领域:
- 儿科健康 儿科健康
- 心理健康 公平 精神健康 公平
- 青少年精神病学 青少年精神病学
背景情况:
- 大型抑郁症影响20%的青少年,自杀是15-24岁年轻人死亡的第二大原因.
- 抑郁症是高度遗传的,父母的抑郁症会对孩子的发展产生负面影响.
- 弱势群体,包括种族/民族少数群体和LGBTQIA+青年,面临更高的抑郁和自杀企图的风险,原因是不良的童年经历和特殊护理障碍.
研究的目的:
- 突出在儿科初级设置中综合心理健康护理的关键需求.
- 倡导儿童医生查抑郁症并评估脆弱年轻人的自杀风险.
- 通过解决获得护理的差异来促进心理健康平等.
主要方法:
- 关于青少年抑郁和自杀的流行病学数据的审查.
- 对脆弱年轻人获得心理健康护理的风险因素和差异的分析.
- 检查儿科初级保健在解决心理健康需求中的作用.
主要成果:
- 青少年,特别是来自边缘化社区的青少年,经历了高水平的抑郁和自杀企图.
- 诸如耻辱和访问问题等障碍限制了与专业心理健康服务的参与.
- 儿科初级保健提供了早期检测和干预的关键途径.
结论:
- 将行为和心理健康护理整合到儿科初级保健中,对于实现心理健康平等至关重要.
- 儿科医生有很好的位置来选抑郁症和自杀风险,与推的能力保持一致.
- 在初级保健中早期识别和干预可以减轻抑郁症的影响,并降低脆弱年轻人中自杀率.
相关概念视频
Depression: Overview
228
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
228
Depressive Disorders: Etiology
59
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
59
Depressive Disorders: MDD and Dysthymia
70
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
70
Cognitive Therapy
147
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
147
Antidepressant Drugs: MAOIs and Other Agents
205
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
205
Antidepressant Drugs: Overview
389
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
389


